Article

wsj.comwsj.com on 2021-08-25 12:13

Pharma’s Appetite for Biotech Deals Bodes Well

This year has been disappointing for biotech investors, but Pfizer’s planned acquisition of Trillium Therapeutics shows things aren’t as bleak as they ...

Related news